Ocean Health Breakthrough: The Ocean Census says it has identified 1,121 previously unknown marine species since last April, including deep-sea “ghost shark” relatives and a mysterious worm living inside a glass sea sponge—another reminder that most ocean life is still a blind spot. Obesity Drug Race: Eli Lilly’s oral obesity pill Foundayo (orforglipron) won FDA approval, intensifying the push for easier-to-take weight-loss medicines as companies compete on results and manufacturing. Safety Alert—Dengue: The CDC reports a sharp rise in dengue in the US in 2024, with most cases linked to travel, and urges stronger prevention and traveler awareness. Rheumatic Heart Disease Research: Ochsner’s Dr. Craig Sable is named a principal investigator in a $15M American Heart Association initiative, with a SHIELD hub also working with partners including Timor-Leste to improve early detection and care. Local Human Impact: A Timor-Leste worker in Australia says a farm job under a labour scheme left him with minimal savings after pay and repayment rules; and in the region, a charity for veterans faces funding cuts, while a hospital denies viral claims it would limit care based on politics.